Thyrofit – 25 (Synthroid)0.25 Mcg – 300 tablets

$14.30

Each Thyrofit 25 contains 25 mcg Thyroxine Sodium 300 tablets and It is used to add thyroid hormone to the body and off label use for fitness.

ATC Classification: H03AA01
Active Ingrediant: Thyroxine Sodium
Generic Name: Thyrofit – 25
Manufacturer: Eris Life
Strength: 0.25 Mcg
Dosage Type: Tabs
Packaging Type: Foil in Box
Contains: 30 Tabs

Description

What is this drug used for?

• It is used to add thyroid hormone to the body.

• It is used to manage thyroid cancer.

• It may be given to you for other reasons. Talk with the doctor.

Frequently reported side effects of this drug

• Hair loss

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• Chest pain

• Fast heartbeat

• Abnormal heartbeat

• Headache

• Dizziness

• Passing out

• Vision changes

• Shortness of breath

• Loss of strength and energy

• Lack of appetite

• Increased appetite

• Excessive weight gain or loss

• Swelling of arms or legs

• Diarrhea

• Abdominal cramps

• Vomiting

• Irritability

• Anxiety

• Emotional instability

• Tremors

• Trouble sleeping

• Temperature sensitivity

• Sweating a lot

• Muscle cramps

• Muscle weakness

• Flushing

• Bone pain

• Menstrual irregularities

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

Note: This is not a comprehensive list of all side effects. Talk to your doctor if you have questions.

 

Pronunciation

(lee voe thye ROKS een)

 

Medication Safety Issues

Sound-alike/look-alike issues:

Levothyroxine may be confused with lamoTRIgine, Lanoxin, levoFLOXacin, liothyronine

Levoxyl may be confused with Lanoxin, Levaquin, Luvox

Synthroid may be confused with Symmetrel

Administration issues:

Significant differences exist between oral and IV dosing. Use caution when converting from one route of administration to another.

Other safety concerns:

To avoid errors due to misinterpretation of a decimal point, always express dosage in mcg (not mg).

 

Generic Availability: US

May be product dependent

 

Storage and Stability

Capsules and tablets: Store at 25°C (77°F); excursions are permitted between 15°C and 30°C (59°F and 86°F). Protect from heat, light, and moisture.

Oral solution (Tirosint): Store in original container (closed aluminum pouch) at 25°C (77°F); excursions are permitted between 15°C and 30°C (59°F and 86°F). Keep ampules in pouch until ready to use; after opening the pouch, all ampules in the pouch should be used within 15 days.

Injection: Store at 20°C to 25°C (68°F to 77°F). Protect from light.

Additional stability data:

Stability in polypropylene syringes (100 mcg/mL in NS) at 5°C ± 1°C is 7 days (Gupta 2000).

Stability in latex-free, PVC minibags protected from light and stored at 15°C to 30°C (59°F to 86°F) was 12 hours for a 2 mcg/mL concentration or 18 hours for a 0.4 mcg/mL concentration in NS. May be exposed to light; however, stability time is significantly reduced, especially for the 2 mcg/mL concentration (Strong 2010).

 

Adverse Reactions

Adverse reactions are primarily those of hyperthyroidism due to therapeutic overdosage.

Cardiovascular: Angina pectoris, cardiac arrhythmia, cardiac failure, flushing, increased blood pressure, increased pulse, myocardial infarction, palpitations, tachycardia

Central nervous system: Anxiety, emotional lability, fatigue, headache, heat intolerance, hyperactivity, insomnia, irritability, myasthenia, nervousness, pseudotumor cerebri (children)

Dermatologic: Alopecia, diaphoresis, skin rash

Endocrine & metabolic: Goiter (exophthalmic; IV), menstrual disease, weight loss

Gastrointestinal: Abdominal cramps, diarrhea, increased appetite, vomiting

Genitourinary: Reduced fertility

Hepatic: Increased liver enzymes

Neuromuscular & skeletal: Decreased bone mineral density, muscle spasm, slipped capital femoral epiphysis (children), tremor

Respiratory: Dyspnea

Miscellaneous: Fever

Rare but important or life-threatening: Dysgeusia (Syed 2016), seizure

Brand

Eris Life

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Reviews

There are no reviews yet.

Be the first to review “Thyrofit – 25 (Synthroid)0.25 Mcg – 300 tablets”

Your email address will not be published.